Bupropion Hydrochloride (xl) Tablet, Extended Release
Product Images NDC 69680-157

This is a description of a medication, containing once-daily extended-release tablet, that can be taken orally. The medication should be taken in the dosage recommended by the physician, and it can be stored at room temperature between 15°C to 30°C (59°F to 86°F). The medication contains an active ingredient IJIH and is distributed by Vitruvias Therapeutics. The medication is manufactured by Hangzhou Minsheng Binjiang Pharmaceutical Co., Ltd. The medication is not to be used in combination with Zyban or any other medicines containing bupropion HC. The enclosed medication guide needs to be dispensed to each patient.*

This is a medication containing bupropion hydrochloride used in the treatment of depression and smoking cessation. The medication is extended-release and each tablet contains 150 mg of bupropion hydrochloride. The usual dosage recommended is one tablet daily, as directed by a physician. The medication should be stored at room temperature and not used in combination with other medicines containing bupropion HCI. The medication is distributed by Vitruvias Therapeutics and manufactured by Hangzhou Minsheng Binjiang Pharmaceutical Co., Ltd, located in Zhejiang, China. A medication guide should be dispensed to each patient.*

This is a description of a medication called "Zyban" which is an extended-release tablet taken once daily as directed by a physician. It contains certain ingredients and is distributed by Vitruvias Therapeutics. However, it includes a warning not to use in combination with Zyban or any other medicine that contains bupropion HCL. This medication comes in a bottle containing 500 tablets and was manufactured in China.*

Each extended-release tablet of the Rxonly drug contains 150mg of bupropion hydrochloride, USP. The medication is used as directed by the physician. The usual prescription is to take one tablet daily. The tablet should be stored at room temperature not exceeding 30°C. Vitruvias Therapeutics distributed the medication which is a registered trademark of GlaxoSmithKline LLC. A Warning is given not to use the medication in combination. A medication guide has been enclosed and should be distributed by the pharmacist to each patient. The tablets are products of China.*

This is a medication guide for Rxonly NDC69680-158-93, which contains bupropion hydrochloride. The tablets are extended-release and contain 300 mg per tablet. The usual dosage is one tablet per day or as directed by a physician. The tablets should be stored at 25°C (77°F), with permitted excursions of 15°C to 30°C (59°F to 86°F). The medication should not be used in combination with Zyban or any other medication containing bupropion HGI. The product is manufactured by Hangzhou Minsheng Binjiang Pharmaceutical Co., Ltd. and distributed by Vitruvias Therapeutics in Auburn, AL. Pharmacists are advised to dispense the enclosed Medication Guide to each patient.*

This is a description for a medication with the brand name "Zyban". It contains extended-release bupropion hydrochloride in a dosage of 300 mg. It is recommended to take one tablet daily or as advised by a physician. There is a warning not to use any other medication in combination with Zyban. The medication requires a pharmacist to dispense a medication guide to each patient. The product is distributed by Vitruvias Therapeutics located in Auburn, AL. The product is manufactured by Binjiang Pharmaceutical Co. in China. Storage of the medication should be at controlled room temperature. The package contains 30 tablets.*

This is a description of a medication called Rxonly NDC 69680-158-92, which has an extended-release formula containing 300mg of bupropion hydrochloride, used for treating depression and smoke cessation. Tablets should be taken once daily or as directed by a physician. It's crucial to keep the tablets between 15°C to 30°C (59°F to 86°F) and not to use it in combination with Zyban® or other medicines with bupropion HCI. The medication guides should be distributed to each patient, and the product is a registered trademark of GlaxoSmithKling LLC distributed by Vitruvias Therapeutics. The medication is manufactured by Hangzhou Minsheng Binjiang Pharmaceutical Co., Ltd.*

The text describes a medication, Rxonly NDC 69680-158-90, containing 300 mg of bupropion hydrochloride, USP, in each extended-release tablet. The medication should be taken once a day as directed by a physician, and the prescribing information should be consulted for dosage information. The tablets are extended-release and should be stored at a temperature between 15°C and 30°C (59°F to 86°F). The medication should not be used in combination with Zyban® or any other medicine containing bupropion HCI. The medication is distributed by Vitruvias Therapeutics and manufactured by Hangzhou Minsheng Binjiang Pharmaceutical Co. Ltd. The text also includes contact information for the manufacturer and advises pharmacists to dispense a medication guide to each patient.*